Clinical Trials Logo

Clinical Trial Summary

This culture system utilizes the special affinity difference of biomedical material coating for different cells to achieve the effect of isolating tumor cells from the blood sample. The coating of the system has the characteristic that to make the WBCs adhesion, but the cancer cells in the blood sample suspend in the culture medium, which achieves the effect of separating cancer cells from the blood. The supernatant with the cancer cells can further be isolated from the cultural system for related analysis and detection to achieve early diagnosis and screening.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04125667
Study type Observational
Source National Taiwan University Hospital
Contact Tai-Horng Young
Phone 886-2-23123456
Email thyoung@ntu.edu.tw
Status Recruiting
Phase
Start date October 31, 2019
Completion date August 31, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Recruiting NCT03738319 - Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
Completed NCT03083093 - CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
Recruiting NCT03882684 - Role of Genomic Imprinting in Cancer Diagnosis
Recruiting NCT02288676 - DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
Not yet recruiting NCT04976426 - Establishment and Clinical Validation of a New Technique for Early Diagnosis of Diabetic Nephropathy
Completed NCT03736304 - The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients N/A
Recruiting NCT02268162 - Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination N/A